78 related articles for article (PubMed ID: 17394508)
1. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies.
Vischioni B; Oudejans JJ; Kruyt FA; Giaccone G; Rodriguez JA
Histopathology; 2007 Apr; 50(5):671-5. PubMed ID: 17394508
[No Abstract] [Full Text] [Related]
2. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
3. Survivin gene expression in early-stage non-small cell lung cancer.
Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
[TBL] [Abstract][Full Text] [Related]
4. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
Shinohara ET; Gonzalez A; Massion PP; Chen H; Li M; Freyer AS; Olson SJ; Andersen JJ; Shyr Y; Carbone DP; Johnson DH; Hallahan DE; Lu B
Cancer; 2005 Apr; 103(8):1685-92. PubMed ID: 15742356
[TBL] [Abstract][Full Text] [Related]
5. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
Fan J; Wang L; Jiang GN; He WX; Ding JA
Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of the small heat-shock protein alpha-B-crystallin in operated-on non-small-cell lung cancer patients: clinical implication.
Cherneva R; Petrov D; Georgiev O; Slavova Y; Toncheva D; Stamenova M; Trifonova N
Eur J Cardiothorac Surg; 2010 Jan; 37(1):44-50. PubMed ID: 19651521
[TBL] [Abstract][Full Text] [Related]
8. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
Leithner K; Stacher E; Wurm R; Ploner F; Quehenberger F; Wohlkoenig C; Bálint Z; Polachova J; Olschewski A; Samonigg H; Popper HH; Olschewski H
Lung Cancer; 2009 Jul; 65(1):98-104. PubMed ID: 19081160
[TBL] [Abstract][Full Text] [Related]
9. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
12. WT-1 immunohistochemical expression in small round blue cell tumours.
McCluggage WG
Histopathology; 2008 Apr; 52(5):631-2. PubMed ID: 18312358
[No Abstract] [Full Text] [Related]
13. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
14. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE
Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of protein kinase C-beta (PKC-beta) in tumour specimens of patients with non-small cell lung cancer.
Lahn M; McClelland P; Ballard D; Mintze K; Thornton D; Sandusky G
Histopathology; 2006 Oct; 49(4):429-31. PubMed ID: 16978209
[No Abstract] [Full Text] [Related]
16. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
Albert JM; Gonzalez A; Massion PP; Chen H; Olson SJ; Shyr Y; Diaz R; Lambright ES; Sandler A; Carbone DP; Putnam JB; Johnson DH; Lu B
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1845-51. PubMed ID: 17855704
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
[TBL] [Abstract][Full Text] [Related]
18. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
[TBL] [Abstract][Full Text] [Related]
19. [Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer].
Zhu ZH; Yang H; Fu JH; Hu Y; Ma Y; Wu QL; Rong TH; Wang DF
Ai Zheng; 2007 Nov; 26(11):1268-71. PubMed ID: 17991331
[TBL] [Abstract][Full Text] [Related]
20. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]